Several recent open studies have provided encouraging results as to the ecacy of intravesical installations of capsaicin for neurogenic hyperre¯ectivity. The present trial was performed to verify these results under controlled conditions. Intravesical installation of capsaicin represents a new therapeutic hope for the treatment of the neurogenic hyperrelfexic bladder. Method: This randomized, double-blind study compared the results of the intravesical installation of 30 mg capsaicin in 100 ml of 30% alcohol (experimental group) with those of installing 100 ml 30% alcohol alone (control group). On day 0 and day 30, urodynamic and biopsic examinations were performed in all subjects of each group. Patients: All the subjects included in the study had a functionally disabling form of neurogenic hyperre¯exic bladder resistant to the usual therapies. Cystoscopy and retrograde cystography were performed to exclude any patient who presented with a tumor-like lesion or had vesicoureteral re¯ux. Results: Twelve paraplegic of tetraplegic subjects, seven women and ®ve men whose average age was 46, were included. Eight had multiple sclerosis, and four had sustained a traumatic spinal cord injury. The patients were randomly separated into two groups of six. Initially, there was no clinical or urodynamic dierences in these groups. Installation immediately triggered side eects and during the ®rst 7 days (suprapubic burning sensation, sensory urgency, hot¯ushes, autonomic hyperre¯exia, hematuria) in ®ve of the six subjects in both groups. Bladder biopsy revealed no signi®cant deterioration. On day 30, there was improvement in all of the experimental-group of patients with signi®cant regression of leakage (P=0.002) and of sensory urgency (P=0.01). Only one control subject had amelioration. Urodynamic examination showed a rise in bladder capacity from 172.5 to 312.3 ml in the experimental group, signi®cantly greater (P=0.03) than the rise from 129 to 175.3 ml observed in the control group. Conclusion: This trial fully con®rms the ecacy of intravesical installations of capsaicin, an ecacy obtained at the cost of nonnegligible side eects. An intermediate-term follow-up of this treatment will be necessary before considering more widespread use of this agent.
Introduction
Studies on spinal cord injured animals 1, 2 and preliminary studies on a small population of spinal cord injured patients 3 suggest that capsaicin-sensitive, C-®ber bladder aerents are involved in pathological conditions associated with a neurogenic hyperre¯exic bladder. Open trials indicate substantial therapeutic potential for intravesical capsaicin treatment of a neurogenic hyperre¯exic detrusor, 4 ± 9 but controlled trials have not yet been published. 7 We report the results of a doubleblind, placebo-controlled study performed to delineate clinical and cystometric eects of intravesical capsaicin treatment, and to provide further data concerning its potential short-term side eects.
Methods

Patients
We included in this protocol patients showing severe neuropathic incontinence resistant to currently avail-able medical treatments. All of these patients had spinal cord disease, considerable detrusor hyperre¯exia.
Patients showing progression of neurological symptoms during the previous 6 months were excluded from our study. Those with urinary tract infection and lithiasis were ruled out or were treated before the capsaicin installation. If there was malignancy or ureteral re¯ux, after cystographic and cystoscopic examinations, patients were excluded.
Twelve patients (seven females, ®ve males) meeting these criteria were included (see Table 1 ). They ranged in age from 38 to 66 years (mean=45.9 years). All patients had spastic paraplegia or tetraplegia. Eight had multiple sclerosis and the other four had either a traumatic spinal cord injury. Among the latter, one had T4 complete paraplegia (ASIA Impairment scale (AIS) grade A), one T10 complete paraplegia (AIS grade A), one C7 complete tetraplegia (AIS grade A), and one C7 incomplete tetraplegia (AIS grade C).
Procedures
The ethics committee of Bordeaux University Hospital approved the protocol. All patients gave personal informed consent to participate in the trial and were randomly assigned to either the trial or control (placebo) groups. Synthetic capsaicin was prepared by the Pharmacy School of the University of Bordeaux.
Twenty minutes after an intravesical installation of 40 ml lidocain (2%) solution, the patients randomly received installation of capsaicin (100 ml of 1 mmol/l [0.3 g/l] solution in 30% alcohol) or placebo (solution of 30% alcohol) during 30 min. All installations were carried out at the hospital as outpatients, and they returned home 1 h after installation.
The subjects were questioned about the clinical eects, especially with regard to incontinence and side eects. Along with these clinical aspects, cystometric parameters volume of the ®rst urge to void, bladder capacity (leak point pressure), and pressure of the detrusor at maximum capacity, were determined at Day 0 (D0) before installation, and 30 days after the installation (D30). Gas cystometric studies (50 ml/mn) were performed with a Urodyn 2000 apparatus (Dantec Inc.). All of patients underwent a rigid cystoscopic examination 3 weeks before the installation, and at D30. A biopsy specimen was obtained from the dome and trigone of the bladder.
The Mann-Whitney nonparametric test was used to compare the two groups at D0 and D30.
Results
Initially the two groups presented no signi®cant dierence in their general characteristics (Table 1) , mode of voiding (Table 2) , or urodynamic parameters ( Table 3) .
The installation induced frequent, but well tolerated side eects (no patient came out of the study) with no signi®cant dierence between the two groups ( Table  4) . Among the side eects occurring during or immediately after the installation were a suprapubic burning sensation (in spite of local anesthesia with lidocain), sensory urgency and/or a hot¯ush in ®ve of six cases in the capsaicin group, and in four of the six control subjects. Only one subject (capsaicin group) developed moderate hyperre¯exia, rapidly regressing after treatment with calcium channel blockers. These immediate symptoms are to be distinguished from delayed side eects arising from 12 h to 6 days after installation: suprapubic pain sensation (SPP) or increasing incontinence (II) or macroscopic haematuria (MH) in ®ve of the six patients in the capsaicin group and in all of the controls. One patient who had autonomic hyperre¯exia was noted in the control group, and another who had symptomatic lower urinary tract infection in the capsaicin group. Urinary retention was not observed in patients who voided voluntarily. The cystoscopies and biopsies performed before and after installation showed only non speci®c aspeci®c alterations of the vesical mucosa, with no dierence between the two groups (the detailed histopathology results will be published separately).
On D30, among the clinical results (Table 2 ) there appeared to be a signi®cant improvement in the frequency of voiding in the capsaicin group in which the average number of daily catheterizations was reduced from 7.3 to 5.1, compared to a smaller reduction in the control group, from 10.8 to 9.3 (P=0.016). Similarly, the number of daily incidents of leakage fell from 3.6 to 0.3 in the capsaicin group compared to the decrease from 5.1 to 4.5 in the controls (P=0.002). The mode of voiding remained unchanged in all of the patients. These results concur well with the subjective judgment of the patients who were all satis®ed in the capsaicin group, compared to only one satis®ed patient amongst the controls.
Urodynamically (Table 3) , the ®rst urge to void was noted at an average volume of 87.3 ml before and 138.1 ml after the installation of capsaicin compared to 94.8 and 107 ml, respectively, in the control group 
Discussion
This is the fourth report concerning the use of intravesical installation of capsaicin for the neurogenic hyperre¯exic bladder, and the ®rst conducted according to the recommendations of Nitti, 7 i.e. double blinded versus placebo. Indeed, although previous works 4 ± 7 have produced very encouraging results, none permitted, from a strictly methodological point of view, armation of the ecacy of capsaicin.
In view of the complexity of the protocol, our trial included only 12 patients, but the two groups were quite homogeneous, initially presenting no dierences in general, clinical and urodynamical characteristics. The other four series 4, 6, 8, 9 included 41, seven, 12 and three patients, respectively. The installation protocol used in our study was strictly that described by Fowler. 5 We obtained detailed data on side eects (Table 4) which were present in almost every patient at the time of the installation (suprapubic burning sensation, sensory urgency, hot¯ush and, more rarely, autonomic hyperre¯exia) as well as within the following 6 days (suprapubic burning sensation, exacerbation of incontinence, macroscopic hematuria). These eects were also reported by the previous authors, who considered them to be clinically tolerable, as did we. As previously stated, none of our subjects at any point requested to drop out of the study.
One of the principal ®ndings of our study was, as had not been anticipated, the absence of more severe or more frequent secondary eects clinically or histologically documented in the capsaicin group in comparison with the control group. This suggests that the solvent of the installed solution, 30% alcohol would be just as deleterious to the bladder mucosa as is capsaicin. Further work is called for in order to improve the quality of the solvent. Igawa, 10 recently observed the absence of autonomic hyperre¯exia in two patients having undergone vesical installation with 10% ethanol alone, whereas it occurred when capsaicin was installed using that solvent. Unfortunately, he made no mention of the other side eects. It is also noteworthy, from a purely methodological standpoint, that the presence of identical side eects in our two groups preserved the double-blind nature of the study consequently reinforcing the reliability of the results.
In terms of clinical ecacy, we found a very marked improvement in leakage and voiding frequency associated with the general satisfaction of the subjects treated with capsaicin. The mode of voiding did not change, but the feeling of greater security in these patients allowed most of them to return to social activities that had previously been limited by their incontinence: shopping, restaurants, movies, the beach, etc. In contrast, in the control group (except for patient 1) the clinical condition remained unchanged without any lasting aggravation. We noticed slight improvement in four of six patients in the control group which could be due to the placebo eect itself or 9 In our study, there were no dierences in ecacy between the spinal cord traumatic injury subjects and those with multiple sclerosis, which corresponds to Geirsson's results in seven spinal injury patients.
The urodynamic data con®rmed the clinical impression and provided interesting complementary information. The principal improvement concerned the peak bladder capacity which increased by 140 ml on the average in the capsaicin group compared to only 46 ml in the controls (r=0.037). This latter increase could be attributed to a placebo eect, to a possible action of the solvent itself, or to a positive anticipatory eect of the examining physician, but which of these is or are responsible remains uncertain.
These values lie in the range of the results reported in the open studies which found average gains of 50 ml for de Ridder, 9 104 ml for Geirsson, 6 and 201 ml for Fowler. 5 An improvement of 140 ml in the bladder capacity should, for a mean hourly diuresis of 50 to 100 ml, result in an increase in the intervoiding period of 1.5 to 3 h. This corresponds quite closely with the reduction in voiding frequency found in our trial.
The bladder capacity corresponding to the initial urge to void tended to be improved in our capsaicin group, but the dierence with controls was not statistically signi®cant. This may have been due to methodological problems ± too few subjects, impossibility of analyzing the urge to void in patients with a complete spinal cord injury. Another possibility that might explain this lack of statistical improvement in initial urge could be the destruction by capsaicin of the nonmyelinated ®bers carrying this signal toward the centers of perception. Upscaling of our study with a greater number of subjects might provide answers to this question which was not directly addressed in the previous reports.
The maximal ®lling bladder pressure, which re¯ects the vesical contractility was decreased in average of 19 cm water, but it did not reach signi®cance. Signi®cance could probably be reached with a greater number of patients. This decrease could explain the decrease of sensation of emergency voiding as well as the leakage. Our data are again comparable to previous studies: Geirsson: 6 7 cm water; Fowler: 5 12 cm; de Ridder: 9 15 cm. This was probably due to the persistence of a certain number of nonmyelinated ®bers which resisted the installation as was suggested by Chandimarami. 8 Another hypothesis to explain the maintenace of bladder activity could be the existence of other neurourological pathways responding to other stimulations.
In summary, urodynamically the situation corresponded to one with slightly attenuated bladder contraction and, above all, more delayed volume evoked contraction. This would explain the absence of any urinary retention and the conservation of the mode of voiding.
Conclusions
This initial double-blind, placebo-controlled trial con®rmed the ecacy of capsaicin for neurogenic hyperre¯exic bladder, ®nding clinical and urodynamic results similar to those of the preliminary open studies with tolerable side eects. However, numerous questions remain to be addressed, in particular concerning the long-term maintenance of eects and tolerance.
We are currently extending our double-blind study, progressively increasing the number of subjects. In parallel, we are carrying out an open medium-term follow-up of patients periodically receiving installations.
